Gene expression profiling for pharmaceutical safety assessment

Expert Opinion on Drug Metabolism and Toxicology

Volumn 1, Issue 2, 2005, Pages 247-260

  Huby, Russell ^a   Tugwood, Jonathan D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

database; front loading; hepatotoxicity; predictive toxicology; toxicogenomics

Indexed keywords

ANIMAL; DRUG DESIGN; DRUG EFFECT; DRUG SCREENING; ECONOMICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METHODOLOGY; PHARMACEUTICS; REVIEW; STANDARD;

ANIMALS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 26944449110     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.1.2.247     Document Type: Review

References (52)

1. OLSON H, BETTON G, ROBINSON D et al.: Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. (2000) 32(1):56-67.
2. NUWAYSIR EF, BITTNER M, TRENT J, BARRETT JC, AFSHARI CA: Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. (1999) 24(3):153-159. (Pubitemid 29169855)
3. LOVETT RA: Toxicogenomics. Toxicologists brace for genomics revolution. Science (2000) 289(5479):536-537. (Pubitemid 30622034)
4. MEDLIN J: Array of hope for gene technology. Environ. Health Perspect. (2001) 109(1):A34-A37. (Pubitemid 32118015)
5. FIELDEN MR, ZACHAREWSKI TR: Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol. Sci. (2001) 60(1):6-10. (Pubitemid 32229821)
6. POGNAN F: Genomics, proteomics and metabonomics in toxicology: hopefully not fashionomics. Pharmacogenomics (2004) 5(7):879-893. (Pubitemid 39386755)
7. ZHAO N, HASHIDA H, TAKAHASHI N, MISUMI Y, SAKAKI Y: High-density cDNA filter analysis: a novel approach for large-scale, quantitative analysis of gene expression. Gene (1995) 156(2):207-213.
8. SCHENA M, SHALON D, DAVIS RW, BROWN PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 270(5235):467-470.
9. DERISI J, PENLAND L, BROWN PO et al.: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. (1996) 14(4):457-460. (Pubitemid 26414590)
10. ALIZADEH AA: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 403(6769):503-511. (Pubitemid 30082188)
11. VEER LJ, DAI H, VAN DE VIJVER MJ et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 415(6871): 530-536. (Pubitemid 34130608)
12. VAN DE VIJVER MJ, HE YD, VANT VEER LJ et al.: A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. (2002) 347(25):1999-2009. (Pubitemid 35461656)
13. ALIZADEH AA, STAUDT LM: Genomicscale gene expression profiling of normal and malignant immune cells. Curr. Opin. Immunol. (2000) 12(2):219-225. (Pubitemid 30133115)
14. BURTON GR, GUAN Y, NAGARAJAN R, MCGEHEE RE Jr: Microarray analysis of gene expression during early adipocyte differentiation. Gene (2002) 293(1-2):21-31. (Pubitemid 34876458)
15. HOFFMANN R, MELCHERS F: A genomic view of lymphocyte development. Curr. Opin. Immunol. (2003) 15(3):239-245. (Pubitemid 36645098)
16. PRZYBORSKI SA, SMITH S, WOOD A: Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells (2003) 21(4):459-471. (Pubitemid 36793488)
17. FESSLER MB, MALCOLM KC, DUNCAN MW, WORTHEN GS: A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J. Biol. Chem. (2002) 277(35):31291-31302. (Pubitemid 34968927)
18. HELLER RA, SCHENA M, CHAI A et al.: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl Acad. Sci. USA (1997) 94(6):2150-2155. (Pubitemid 27136843)
19. RICCIARDI-CASTAGNOLI P, GRANUCCI F: Opinion: Interpretation of the complexity of innate immune responses by functional genomics. Nat. Rev. Immunol. (2002) 2(11):881-889.
20. HAMALAINEN H, ZHOU H, CHOU W, HASHIZUME H, HELLER R, LAHESMAA R: Distinct gene expression profiles of human Type 1 and Type 2 T helper cells. Genome Biol. (2001) 2(7):RESEARCH0022.
21. GHAEMMAGHAMI S, HUH WK, BOWER K et al.: Global analysis of protein expression in yeast. Nature (2003) 425(6959):737-741. (Pubitemid 37314318)
22. LEE I, DATE SV, ADAI AT, MARCOTTE EM: A probabilistic functional network of yeast genes. Science (2004) 306(5701):1555-1558. (Pubitemid 39564951)
23. HUGHES TR, ROBINSON MD, MITSAKAKIS N, JOHNSTON M: The promise of functional genomics: completing the encyclopedia of a cell. Curr. Opin. Microbiol. (2004) 7(5):546-554. (Pubitemid 39297136)
24. JANSEN R, YU H, GREENBAUM D et al.: A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science (2003) 302(5644):449-453. (Pubitemid 37296271)
25. WATERS MD, FOSTEL JM: Toxicogenomics and systems toxicology: aims and prospects. Nat. Rev. Genet. (2004) 5(12):936-948. (Pubitemid 39564256)
26. HOLDEN PR, JAMES NH, BROOKS AN, ROBERTS RA, KIMBER I, PENNIE WD: Identification of a possible association between carbon tetrachlorideinduced hepatotoxicity and interleukin-8 expression. J. Biochem. Mol. Toxicol. (2000) 14(5):283-290.
27. UEDA A, HAMADEH HK, WEBB HK et al.: Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. (2002) 61(1):1-6. (Pubitemid 34049505)
28. HAMADEH HK, BUSHEL PR, JAYADEV S et al.: Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. (2002) 67(2):219-231. (Pubitemid 34746475)
29. CHEN H, LIU J, MERRICK BA, WAALKES MP: Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol. Carcinog. (2001) 30(2):79-87.
30. LU T, LIU J, LECLUYSE EL, ZHOU YS, CHENG ML, WAALKES MP: Application of cDNA microarray to the study of arsenicinduced liver diseases in the population of Guizhou, China. Toxicol. Sci. (2001) 59(1):185-192. (Pubitemid 32117995)
31. YIH LH, PECK K, LEE TC: Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis (2002) 23(5):867-876. (Pubitemid 34567528)
32. LOGUINOV AV, ANDERSON LM, CROSBY GJ, YUKHANANOV RY: Gene expression following acute morphine administration. Physiol. Genomics (2001) 6(3):169-181. (Pubitemid 33676486)
33. SATO H, SAGAI M, SUZUKI KT, AOKI Y: Identification, by cDNA microarray, of A-raf and proliferating cell nuclear antigen as genes induced in rat lung by exposure to diesel exhaust. Res. Commun. Mol. Pathol. Pharmacol. (1999) 105(1-2):77-86. (Pubitemid 30395498)
34. BOUTON CM, HOSSAIN MA, FRELIN LP, LATERRA J, PEVSNER J: Microarray analysis of differential gene expression in lead-exposed astrocytes. Toxicol. Appl. Pharmacol. (2001) 176(1):34-53. (Pubitemid 32977289)
35. BULERA SJ, EDDY SM, FERGUSON E et al.: RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology (2001) 33(5):1239-1258. (Pubitemid 32378225)
36. HUANG Q, JIN X, GAILLARD ET et al.: Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mutat. Res. (2004) 549(1-2):147-167.
37. BURCZYNSKI ME, MCMILLIAN M, CIERVO J et al.: Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. (2000) 58(2):399-415. (Pubitemid 32042437)
38. WARING JF, CIURLIONIS R, JOLLY RA, HEINDEL M, ULRICH RG: Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. (2001) 120(1-3):359-368. (Pubitemid 32375103)
39. WARING JF, JOLLY RA, CIURLIONIS R et al.: Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl. Pharmacol. (2001) 175(1):28-42. (Pubitemid 32783533)
40. AMIN RP, VICKERS AE, SISTARE F et al.: Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. (2004) 112(4):465-479. (Pubitemid 38404558)
41. BARTOSIEWICZ M, PENN S, BUCKPITT A: Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. (2001) 109(1):71-74. (Pubitemid 32118029)
42. ELLINGER-ZIEGELBAUER H, STUART B, WAHLE B, BOMANN W, AHR HJ: Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. (2004) 77(1):19-34. (Pubitemid 38128642)
43. AHR HJ: Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. (2004) 77(1):19-34.
44. HAMADEH HK, BUSHEL PR, JAYADEV S et al.: Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. (2002) 67(2):232-240. (Pubitemid 34746476)
45. SLONIM DK: From patterns to pathways: gene expression data analysis comes of age. Nat. Genet. (2002) 32(Suppl.):502-508. (Pubitemid 35435153)
46. MATTES WB, PETTIT SD, SANSONE SA, BUSHEL PR, WATERS MD: Database development in toxicogenomics: issues and efforts. Environ. Health Perspect. (2004) 112(4):495-505. (Pubitemid 38404561)
47. STEINER G, SUTER L, BOESS F et al.: Discriminating different classes of toxicants by transcript profiling. Environ. Health Perspect. (2004) 112(12):1236-1248. (Pubitemid 39199564)
48. SALTER AH, NILSSON KC: Informatics and multivariate analysis of toxicogenomics data. Curr. Opin. Drug Discov. Devel. (2003) 6(1):117-122. (Pubitemid 36210927)
49. PACKEISEN J, KORSCHING E, HERBST H, BOECKER W, BUERGER H: Demystified.tissue microarray technology. Mol Pathol (2003) 56(4):198-204.
50. SIMON R, MIRLACHER M, SAUTER G: Tissue microarrays. Biotechniques (2004) 36(1):98-105. (Pubitemid 38076386)
51. SUTER L, HAIKER M, DE VERA MC, ALBERTINI S: Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach. Pharmacogenomics J. (2003) 3(6):320-334. (Pubitemid 38072170)
52. http://www.niehs.nih.gov/nct/glossary.htm National Center For Toxicogenomics website (2005).